Misplaced Pages

Olpadronic acid

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by DMacks (talk | contribs) at 05:30, 17 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Misplaced Pages talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 05:30, 17 June 2020 by DMacks (talk | contribs) (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Misplaced Pages talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
Olpadronic acid
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • bis(phosphonic acid)
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC5H15NO7P2
Molar mass263.123 g·mol
3D model (JSmol)
SMILES
  • CN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
InChI
  • InChI=1S/C5H15NO7P2/c1-6(2)4-3-5(7,14(8,9)10)15(11,12)13/h7H,3-4H2,1-2H3,(H2,8,9,10)(H2,11,12,13)
  • Key:UGEPSJNLORCRBO-UHFFFAOYSA-N
  (what is this?)  (verify)

Olpadronic acid (INN; salt form olpadronate) is a bisphosphonate. It is used as part of a cancer symptom treatment support in cases of high blood calcium levels (hypercalcemia) and the reduction of fractures/pain that are the result of when cancer spreads to the bone (metastasis).

References

  1. "Zoledronic Acid - Chemotherapy Drugs - Chemocare". chemocare.com. Retrieved 2018-12-23.
Drugs for treatment of bone diseases (M05)
Bisphosphonates
Bone morphogenetic proteins
Other


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it.

Categories: